Grace Therapeutics has a total of 20 patents globally, out of which 2 have been granted. Of these 20 patents, more than 60% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Grace Therapeutics.
Grace Therapeutics was founded in the year 2014. The Company is a pharmaceutical company with a focus on rare and orphan diseases. Company’s strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique evidence-based and outcomes-driven value proposition.
Do read about some of the most popular patents of Grace Therapeutics which have been covered by us in this article and also you can find Grace Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Grace Therapeutics patent portfolio.
How many patents does the founder of Grace Therapeutics have?
The founder George Kottayil has 0 patent and Vimal Kavuru has 5 patents.
How many patents does Grace Therapeutics have?
Grace Therapeutics has a total of 20 patents globally. These patents belong to 5 unique patent families. Out of 20 patents, 12 patents are active.
How Many Patents did Grace Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Grace Therapeutics Applications Filed | Grace Therapeutics Patents Granted |
| 2023 | 2 | – |
| 2022 | 2 | 1 |
| 2021 | – | 1 |
| 2020 | 1 | – |
| 2019 | 2 | – |
| 2017 | 6 | – |
| 2016 | 7 | – |
How many Grace Therapeutics patents are Alive/Dead?
How Many Patents did Grace Therapeutics File in Different Countries?
Countries in which Grace Therapeutics Filed Patents
| Country | Patents |
| Canada | 4 |
| United States Of America | 4 |
| Hong Kong (S.A.R.) | 4 |
| China | 3 |
| Eurasia | 1 |
| Korea (South) | 1 |
Where are Research Centres of Grace Therapeutics Patents Located?
The Research Centre for all the Grace Therapeutics patents is the United States of America.
Best Grace Therapeutics Patents
US20170296485A1 is the most popular patent in the Grace Therapeutics portfolio. It has received 5 citations so far from companies like Inclusion GmbH, Celista Pharmaceuticals Llc and Kobayashi Pharmaceutical Co., Ltd.
What Percentage of Grace Therapeutics US Patent Applications were Granted?
Grace Therapeutics (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 60.0%.
Below are the key stats of Grace Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Grace Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Davidson Davidson & Kappel Llc | 14 | 60.00% |
List of Grace Therapeutics Patents
| Grace Therapeutics Patents | Title |
| CN108738309B | Sprays That Form A Topical Film |
| CN114886850A | Nimodipine Formulations And Methods Of Treating Conditions |
| CA3005150C | Topical Film-Forming Spray |
| CA3122363A1 | Therapeutic Composition Of Intranasal Lidocaine |
| CA3021237A1 | Stable Nimodipine Parenteral Formulation |
| CA3011015A1 | Betamethasone Oral Spray Formulation And Method Of Use To Treat Ataxia |
| HK40077694A | Stable Nimodipine Parenteral Formulation |
| HK40077176A | Nimodipine Formulation And Method Of Treating Conditions |
| HK40063645A | Therapeutic Composition Of Intranasal Lidocaine |
| HK40062158A | Therapeutic Composition Of Intranasal Lidocaine |
| EA201891225A1 | Film-Forming Spray For Topical Application |
| KR1020180088415A | Topical Film-Forming Spray |
| US20200397769A1 | Stable Nimodipine Parenteral Formulation |
| US20190255033A1 | Stable Nimodipine Parenteral Formulation |
| US20170296484A1 | Topical Film-Forming Spray |
| US20170296485A1 | Topical Film-Forming Spray |
| CN109069651A | Stable Nimopidine Parenteral Formulation |
| WO2017091739A8 | Topical Film-Forming Spray |
| WO2017180718A1 | Stable Nimopidine Parenteral Formulation |
| WO2017123744A1 | Betamethasone Oral Spray Formulation And Method Of Use To Treat Ataxia |
What are Grace Therapeutics key innovation segments?
What Technologies are Covered by Grace Therapeutics?
The chart below distributes patents filed by Grace Therapeutics